CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNY

Frexalimab

Phase 3
Sanofi (SNY)

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
SNYPhase 3

Frexalimab Phase 3 Est. Readout

Frexalimab
Q2 2027~QSTALE
CT.gov
00%
Q2 '27
SNYPhase 2

Frexalimab Phase 2 Est. Readout

Frexalimab
Q2 2027~QSTALE
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Type 1 Diabetes Mellitus

Clinical Trial

NCT06111586

Last updated: 12/29/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.